Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pearson

Showing results (1191-1200 of 1,239) with videos related to

Pageof 124
Sort By:
Physical Review Letters|March 17, 2011
High-precision half-life measurement for the superallowed β+ emitter ²⁶Al(m)P Finlay, S Ettenauer, G C Ball, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Physical Review Letters|June 4, 2008
Internal gamma decay and the superallowed branching ratio for the beta(+) emitter (38)K(m)K G Leach, C E Svensson, G C Ball, et al.
Cell Metabolism|December 6, 2024
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in miceXinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, et al.
Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Cytochrome <i>b</i><sub></sub> reductase and the control of lipid metabolism and healthspanAlejandro Martin-Montalvo, Yaning Sun, Alberto Diaz-Ruiz, et al.
Cancer Cell|July 14, 2012
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaTeeara Berry, William Luther, Namrata Bhatnagar, et al.
Pageof 124

Showing results (1191-1200 of 1,239) with videos related to

Sort By:
Pageof 124
Physical Review Letters|March 17, 2011
High-precision half-life measurement for the superallowed β+ emitter ²⁶Al(m)P Finlay, S Ettenauer, G C Ball, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.
Ophthalmology|June 17, 2022
Adeno-Associated Virus Serotype 2-hCHM Subretinal Delivery to the Macula in Choroideremia: Two-Year Interim Results of an Ongoing Phase I/II Gene Therapy TrialTomas S Aleman, Rachel M Huckfeldt, Leona W Serrano, et al.
The Canadian Journal of Cardiology|January 29, 2013
2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adultTodd J Anderson, Jean Grégoire, Robert A Hegele, et al.
Physical Review Letters|June 4, 2008
Internal gamma decay and the superallowed branching ratio for the beta(+) emitter (38)K(m)K G Leach, C E Svensson, G C Ball, et al.
Cell Metabolism|December 6, 2024
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in miceXinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, et al.
Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
The Lancet. Oncology|March 6, 2017
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trialRuth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, et al.
NPJ Aging and Mechanisms of Disease|July 20, 2017
Cytochrome <i>b</i><sub></sub> reductase and the control of lipid metabolism and healthspanAlejandro Martin-Montalvo, Yaning Sun, Alberto Diaz-Ruiz, et al.
Cancer Cell|July 14, 2012
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastomaTeeara Berry, William Luther, Namrata Bhatnagar, et al.
Pageof 124